vimarsana.com
Home
Live Updates
Elgan Pharma Announces Positive Results from its Phase III S
Elgan Pharma Announces Positive Results from its Phase III S
Elgan Pharma Announces Positive Results from its Phase III Study of ELGN-GI in Preterm Infants for Treatment of Intestinal Malabsorption
/PRNewswire/ -- Elgan Pharma, a late-stage clinical biopharmaceutical company focusing on innovative treatments for critical conditions in neonates, announced...
Related Keywords
Israel ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Tsipi Haitovsky ,
Miki Olshansky ,
Hans Van Goudoever ,
Elgan Pharma ,
University Of Amsterdam ,
Division Chair ,
Gemma Children ,
Hospital Amsterdam ,
Town Milk ,
Gastrointestinal Complications ,